Global Manual Blood Collection Product Market Size By Type (Blood Collection Tubes, Needles and Syringes), By Application (Hospitals and Pathology Laboratories, Blood Banks), By Region, And Segment Fo...

The Global Manual Blood Collection Product Market was valued at USD 1.1 billion in 2023 and is projected to reach USD 1.83 billion by 2031, growing at a CAGR of 6.5% during the forecast period from 2023 to 2031. The market is expanding steadily, driven by the increasing need for blood diagnostics, rising prevalence of chronic diseases, and a growing global aging population. Manual blood collection devices, such as needles, syringes, and collection tubes, continue to be essential in medical diagnostics due to their cost-effectiveness, ease of use, and suitability in low-resource settings.

Drivers:

1. Growing Demand for Diagnostic Testing:

The increase in the incidence of diseases such as diabetes, anemia, and infectious diseases is driving the demand for diagnostic blood testing, thereby boosting the manual blood collection product market.

2. Rising Geriatric Population:

An aging population is more prone to health issues, resulting in frequent medical tests. This demographic shift is expected to significantly contribute to the market’s growth.

3. Expansion of Healthcare Facilities in Emerging Economies:

The development of healthcare infrastructure in emerging countries is facilitating access to essential diagnostic services, including manual blood collection.

Restraints:

1. Risk of Needle Stick Injuries and Infections:

Healthcare professionals using manual blood collection tools face risks of accidental injuries and exposure to blood-borne infections, which may limit market adoption without appropriate training or safety innovations.

2. Increasing Preference for Automated and Minimally Invasive Technologies:

The shift towards automated blood collection and needle-free sampling methods in developed economies can restrain market growth for manual products.

Opportunity:

1. High Demand in Low- and Middle-Income Countries (LMICs):

Manual blood collection products are cost-effective and ideal for LMICs where advanced diagnostic technologies may not be widely accessible.

2. Product Innovations and Safety Enhancements:

Manufacturers are investing in innovations like safety-engineered needles and vacuum-based blood collection systems, creating new growth opportunities.

Market by System Type Insights:

By system type, Needles and Syringes held the dominant market share in 2023 due to their widespread use in phlebotomy across hospitals, clinics, and laboratories. The Vacuum Blood Collection Tubes segment is expected to grow significantly during the forecast period, owing to their role in improving sample integrity and reducing contamination risks.

Market by End-use Insights:

In terms of end-use, Hospitals & Clinics accounted for the largest market share in 2023. These facilities perform high volumes of diagnostic tests and have consistent demand for manual blood collection tools. Diagnostic Laboratories represent the fastest-growing segment, supported by the rise in preventive healthcare and an increasing number of standalone lab chains.

Market by Regional Insights:

North America dominated the global market in 2023, supported by a robust healthcare system, high diagnostic test volume, and the presence of major manufacturers. However, Asia-Pacific is poised to experience the fastest growth, attributed to rapid urbanization, rising healthcare awareness, and increased investment in healthcare infrastructure in countries like India and China.

Competitive Scenario:

Leading companies in the Global Manual Blood Collection Product Market include Becton, Dickinson and Company (BD), Terumo Corporation, Greiner Bio-One, SARSTEDT AG & Co. KG, Nipro Medical Corporation, Improve Medical, and FL Medical. These firms are actively focusing on expanding product lines, improving safety features, and engaging in strategic partnerships to gain competitive advantages.

Scope of Work – Global Manual Blood Collection Product Market

Report Metric Details

Market Size (2023) USD 1.1 billion

Projected Market Size (2031) USD 1.83 billion

CAGR (2023-2031) 6.5%

Market Segments System Type (Needles, Tubes, Syringes), End-use, Region

Growth Drivers Rise in chronic diseases, aging population, healthcare expansion

Opportunities LMIC demand, safety product innovations

Key Market Developments:

2023: BD introduced an enhanced line of safety syringes designed to reduce needle-stick injuries and improve blood draw accuracy.

2024: Terumo launched a new series of vacuum blood collection systems targeted at emerging markets, with simplified usage protocols.

2025: SARSTEDT expanded its manufacturing capacity in Asia-Pacific to meet the growing regional demand.

FAQs:

1) What is the current market size of the Global Manual Blood Collection Product Market?

The market was valued at USD 1.1 billion in 2023.

2) What is the major growth driver of the Global Manual Blood Collection Product Market?

The major growth driver is the rising demand for diagnostic testing due to chronic disease prevalence and aging populations.

3) Which is the largest region during the forecast period in the Global Manual Blood Collection Product Market?

North America held the largest market share in 2023, but Asia-Pacific is projected to witness the fastest growth.

4) Which segment accounted for the largest market share in Global Manual Blood Collection Product Market?

The Needles and Syringes segment held the largest share by system type, while Hospitals & Clinics led by end-use.

5) Who are the key market players in the Global Manual Blood Collection Product Market?

Key players include BD, Terumo Corporation, Greiner Bio-One, SARSTEDT, and Nipro Medical Corporation.